LecSmart is a proprietary, specialized functional nutraceutical, derived from wheat grain, which has been developed to control harmful microbes in the stomach. These microbes are widespread in humans and are responsible for chronic gastric distress, ulcers, and other gastrointestinal complaints, which do not respond to over-the-counter remedies.

After many years of research and development, including pilot clinical trials, LecSmart has emerged as a highly effective agent for providing relief from gastritis and ulcers caused by Helicobacter pylori. "It is the only such product, other than antibiotics, which actually treats the cause of these diseases rather than just alleviating symptoms," according to Dr. Howard Krivan, President and Chief Science Officer of Lectin Labs, and the inventor of LecSmart. He adds that "LecSmart is manufactured from cereal grain and is, therefore, all-natural, highly palatable, and very safe to use. LecSmart is based on a class of proteins called lectins, which the Company has found, have the ability to bind specifically to harmful bacteria and make them incapable of causing disease. Moreover, this happens in a way which makes it very unlikely for bacteria to mutate into resistant forms, which is a very serious problem that has caused the effectiveness of antibiotics to be diminished." Dr. Krivan says that a randomized, placebo-controlled clinical trial is currently ongoing in Ventura, CA.

According to Luis Vega, CEO of Lectin Labs: "I am very fortunate to be a part of the launch of LecSmart and very gratified by the success we have seen with the product in the support of gastric health. It is even more exciting to consider that LecSmart is merely the tip of the iceberg for commercializing the numerous lectin-based products which we have under development for a wide range of medical problems." Lectin Labs Ltd. is an affiliate of Legere Pharmaceuticals, Ltd., a privately held Delaware corporation based in Carson City, NV. In addition to the development of functional nutraceuticals such as LecSmart, the Company's core business is the development of unique pharmaceuticals based on the novel antimicrobial properties of botanically sourced lectin proteins. This includes the development of products for combating soldier diarrhea and sexually transmitted diseases, foremost among which is a promising microbicide for empowering women for the prevention of HIV/AIDS. The Company holds numerous U.S. and international patents on its lectin technologies.